Royce & Associates’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,279,725
Closed -$7.26M 1356
2014
Q4
$7.26M Sell
1,279,725
-15,000
-1% -$80.8K 0.03% 699
2014
Q3
$6.4M Sell
1,294,725
-410,000
-24% -$2.22M 0.02% 749
2014
Q2
$9.72M Sell
1,704,725
-25,000
-1% -$149K 0.03% 684
2014
Q1
$12.8M Buy
1,729,725
+15,000
+0.9% +$110K 0.04% 562
2013
Q4
$12.3M Buy
1,714,725
+102,000
+6% +$757K 0.04% 592
2013
Q3
$12.5M Sell
1,612,725
-20,000
-1% -$155K 0.04% 566
2013
Q2
$10.6M Buy
+1,632,725
New +$10.3M 0.03% 601

Other funds holding ELX

Royce & Associates's ELX Position: Q1 2015 in Review

Royce & Associates sold out of EMULEX CORP (ELX) in Q1 2015, closing a stake of 1,279,725 shares — an estimated $7.26M sold.

Royce & Associates first reported a position in ELX in Q2 2013 and held it in 7 quarters. The position peaked at $12.8M in Q1 2014. 138 funds tracked by Wall St. Rank hold ELX as of Q1 2015.

  • Royce & Associates reported no remaining EMULEX CORP position as of Q1 2015 after selling out during the quarter.
  • Royce & Associates sold 1,279,725 EMULEX CORP shares in Q1 2015, an estimated $7.26M.
  • Royce & Associates first reported a position in EMULEX CORP in Q2 2013 and held it in 7 quarters.
  • Royce & Associates's EMULEX CORP position peaked at $12.8M in Q1 2014.
  • 138 funds tracked by Wall St. Rank held EMULEX CORP as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.